Delivery Order SPE2DR25D2206-SPE2DR26F9BS7
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $18,837.70 delivery order on August 19, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.93 by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Remicade 100 mg vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is executed as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,495.88 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract was executed on October 20, 2025, with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Remicade 100 mg vials, with a contract ceiling value of $27,685.64 and an ultimate completion date of July 30, 2025. This award is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The order represents a child contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg vials of Remicade, a biologic immunosuppressant medication commonly used to treat inflammatory conditions. This firm fixed-price delivery order, valued at $45,100.15, was competitively awarded without set-aside designation and carries an ultimate completion date of October 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on...
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $15,359.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a continuation of AmerisourceBergen's role as a critical supplier of pharmaceutical products to the federal healthcare system. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.60 to AmerisourceBergen Drug Corp for Remicade 100 mg vials, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $38,665.68 by the Defense Logistics Agency on August 27, 2025, for the supply of Remicade 100 mg vials. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9BS7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,146.30 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of November 17, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor on the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support defense healthcare programs globally. This delivery order for Remicade, a biologic immunosuppressant medication commonly used in treating inflammatory diseases, exemplifies the company's role in fulfilling specialized pharmaceutical needs for federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 11/14/25 |